APP and Alzheimer disease: Oraladministration of quercetin in rats with AlCl3-induced AD symptoms reducedAβ aggregation in the hippocampus owing to a downregulation of APP, BACE1,APH1, and PSEN1 and overexpression of ADAM10 and ADAM17 [194].